Alzamend Neuro Inc Financial Flexibility Index
Alzamend Neuro Inc financial flexibility index. Alzamend Neuro Inc (ALZN) has a Financial Flexibility Index of -0.42x as of July 2026. Free cash flow of $-1.14 Million (operating CF $-1.14 Million minus capex $0.00) represents 0% of total liabilities ($2.74 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Alzamend Neuro Inc (2016–2026)
Financial flexibility index of Alzamend Neuro Inc from 2016 to 2026. Historical Financial Flexibility Index trend for Alzamend Neuro Inc across 11 annual periods. Explore Alzamend Neuro Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Alzamend Neuro Inc Financial Flexibility Index by Year (2016–2026)
Alzamend Neuro Inc financial flexibility index by year from 2016 to 2026. Year-by-year free cash flow to debt coverage for Alzamend Neuro Inc. For the full cash flow conversion analysis, see ALZN operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -5.99x | $-8.07 Million | $-8.07 Million | $1.35 Million | ▲ +39.3% |
| 2025 | -9.87x | $-6.27 Million | $-6.57 Million | $634.76K | ▼ -292.2% |
| 2024 | -2.52x | $-8.12 Million | $-8.27 Million | $3.23 Million | ▲ +19.0% |
| 2023 | -3.11x | $-8.92 Million | $-8.92 Million | $2.87 Million | ▲ +44.3% |
| 2022 | -5.59x | $-6.51 Million | $-6.61 Million | $1.16 Million | ▼ -92.9% |
| 2021 | -2.90x | $-2.61 Million | $-2.71 Million | $899.64K | ▼ -28.3% |
| 2020 | -2.26x | $-2.24 Million | $-2.35 Million | $992.31K | ▼ -184.6% |
| 2019 | -0.79x | $-938.74K | $-1.05 Million | $1.18 Million | ▲ +96.3% |
| 2018 | -21.21x | $-2.05 Million | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $-18.49K | $30.72K | — |